< Back to companies
Celemics (셀레믹스)

Celemics (셀레믹스)

Seoul, South Korea

Celemics is a biotech company developing Innovative NGS-based materials through novel sequencing technology to disrupt the paradigm of the medicine, biopharma, AgBio, synthetic biology, and microbiome industries. Celemics has developed the MSSIC platform to provide customized target capture probes with advanced genome analysis capabilities to accelerate drug discovery for immune profiling and antibody library sequencing purposes. As a manufacturer of hybridization captured target enrichment kits for NGS applications, Celemics secured itself as one of the frontrunners in the global genetic testing market. Celemics offers defined panels and customized target enrichment kits in the IVD and RUO sectors with remarkable synthetic probe rebalancing technologies under stringent quality management systems (ISO 9001, ISO 13485, GMP).

Share
Shareable draft
Get Involved in Celemics (셀레믹스)

Company Info

Founded
2010
Website
www.celemics.com/

Categories

BiotechDrug DiscoveryMolecular DiagnosticsLife Sciences

Disease Areas

Technologies

Next-Generation SequencingGenomicsSynthetic BiologyMolecular Diagnostics
Only accessible to MedStartr community members. Join now

What do you think of Celemics (셀레믹스)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Celemics (셀레믹스)
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free